Summary
Pharmacokinetics of conventional 80 mg tablets and two types of sustained-release (SR) tablets containing 120 and 200 mg of verapamil were compared cross-over in 12 healthy volunteers. Serum concentrations of verapamil and norverapamil were analyzed both after a single oral dose and at steady state after t.i.d. administration of conventional tablets and b.i.d. administration of SR tablets. After 120 mg SR tablets serum concentrations of verapamil usually remained below 100 ng/ml for 5 days. This inadequate bioavailability was caused by very slow absorption. The relative bioavailability of verapamil in 200 mg SR tablets was 93–96% as compared to the conventional tablets. After 200 mg × 2 and 80 mg × 3 , the peak serum levels were about 300 and 190 ng/ml, respectively and the trough levels 123–153 and 52–56 ng/ml, respectively. The verapamil/norverapamil ratio varied from 0.69 to 0.84 after a single dose and from 0.8 to 0.93 at steady-state. By the 4th days of treatment, the accumulation ratios ranged between 1.75–2.07 and 1.30–1.75 for verapamil and norverapamil, respectively. For each preparation studied, the apparent Cl101 of verapamil was significantly reduced at steady-state. These results show that 200 mg SR verapamil tablets fulfill the basic requirements of retard preparations allowing for twice or even once daily administration.
Similar content being viewed by others
References
Rawlins M.D. (1979): Drug absorption and bioavailability: the 1980’s. In: Drug Absorption, Prescott L.F. and Nimmo W.S. (eds.). ADIS Press, Sydney.
McAllister R.G. and Kirsten E.B. (1982): The pharmacology of verapamil. IV. Kinetic and dynamic effects after single intravenous and oral doses. Clin. Pharmacol. Ther.,31, 418–426.
Eichelbaum M., Somogyi A., von Unruh G.E. and Dengler H.J. (1981): Simultaneous determination of the intravenous and oral pharmacokinetic parameters of D,Lverapamil using stabile isotope-labelled verapamil. Eur. J. Clin. Pharmacol.,19, 133–137.
Koike Y., Shimamura K., Shudo I. and Saito H. (1979): Pharmacokinetics of verapamil in man. Res. Comm. Chem. Path. Pharmacol.,24, 37–47.
Meier J., Nüesch E. and Schmidt R. (1974): Pharmacokinetic criteria for the evaluation of retard formulations. Eur. J. Clin. Pharmacol.,7, 429–432.
McMahon T.V. and Sheaffer S.L. (1982): Verapamil. Drug Intell. Clin. Pharm.,16, 443–447.
Frishman W., Kirsten E., Klein M., Pine M., Johnson S.M., Hillis L.D., Packer M. and Kates R. (1982): Clinical relevance of verapamil plasma levels in stabile angina pectoris. Am. J. Cardiol.,50, 1180–1185.
Reiter M.J., Shand D.G. and Pritchett E.L.C. (1982): Comparison of intravenous and oral verapamil dosing. Clin. Pharmacol. Ther.,32, 711–720.
Freedman S.B., Richmond D.R., Ashley J.J. and Kelly D.T. (1981): Verapamil kinetics in normal subjects and patients with coronary artery spasm. Clin. Pharmacol. Ther.,30, 644–652.
Kates R.E., Keefe D.L.D., Schwartz J., Harapat S., Kirsten E.B. and Harrison D.C. (1981): Verapamil disposition kinetics in chronic atrial fibrillation. Clin. Pharmacol. Ther.,30, 44–51
Shand D.G., Hammill S.C., Aanonsen L. and Pritchett E.L.C. (1981): Reduced verapamil clearance during long-term oral administration. Clin. Pharmacol. Ther.,30, 701–703.
Wood A.J.J., Carr K., Vestal R.E., Belcher S., Wilkinson G.R. and Shand D.G. (1978): Direct measurement of propranolol bioavailability during accumulation to steady-state. Br. J. Clin. Pharmacol.,6, 345–350.
Kendall M.J., John V.A., Quarterman C.P. and Welling P.G. (1980): A single and multiple dose pharmacokinetic and pharmacodynamic comparison of conventional and slow-release metoprolol. Eur. J. Clin. Pharmacol.,17, 87–92.
Meffin P.J., Winkle R.A., Peters F.A. and Harrison D.C. (1978): Dose-dependent acebutolol disposition after oral administration. Clin. Pharmacol. Ther.,24, 542–547.
Kates R.E. (1983): Calcium antagonists pharmacokinetic properties. Drugs,25, 113–124.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mattila, J., Mäntylä, R., Taskinen, J. et al. Pharmacokinetics of sustained-release verapamil after a single administration and at steady state. European Journal of Drug Metabolism and Pharmacokinetics 10, 133–138 (1985). https://doi.org/10.1007/BF03189707
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03189707